Encompass Health Co. (NYSE:EHC) Shares Bought by California Public Employees Retirement System

California Public Employees Retirement System increased its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 160.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 515,717 shares of the company's stock after buying an additional 317,730 shares during the quarter. California Public Employees Retirement System owned about 0.51% of Encompass Health worth $34,409,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health during the fourth quarter worth $30,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Encompass Health during the third quarter worth $35,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Encompass Health during the third quarter worth $109,000. Acadian Asset Management LLC bought a new stake in shares of Encompass Health during the third quarter worth $111,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Encompass Health by 14.7% during the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company's stock worth $182,000 after purchasing an additional 347 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 0.3 %

EHC traded down $0.26 on Friday, hitting $82.47. The company had a trading volume of 706,619 shares, compared to its average volume of 756,857. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $85.84. The stock has a market capitalization of $8.26 billion, a price-to-earnings ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. The stock has a fifty day moving average price of $78.25 and a 200-day moving average price of $70.91.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the firm earned $0.88 earnings per share. The company's revenue was up 13.4% on a year-over-year basis. Analysts predict that Encompass Health Co. will post 4.04 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.73%. Encompass Health's payout ratio is 16.22%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on EHC. Royal Bank of Canada reiterated an "outperform" rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Raymond James restated a "strong-buy" rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday. Truist Financial raised their price target on Encompass Health from $82.00 to $86.00 and gave the company a "buy" rating in a research note on Friday, February 9th. William Blair restated an "outperform" rating on shares of Encompass Health in a research note on Wednesday, February 7th. Finally, Mizuho raised their price target on Encompass Health from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Thursday. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $86.56.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.